Literature DB >> 2471501

Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors.

M Papotti1, C Paties, V Peveri, L Moscuzza, G Bussolati.   

Abstract

Prostate Specific Antigen (PSA) is regarded as a specific marker of prostatic epithelium and has never been detected by immunocytochemistry in extra-prostatic tissues. The casual finding of a strong positivity for polyclonal antisera to PSA in a sweat gland carcinoma prompted a study on a series of skin adnexial and breast specimens (normal and neoplastic). Normal axillary and perineal apocrine sweat glands, some apocrine foci in fibrocystic breast disease and two sweat gland and two breast apocrine carcinomas were stained by several PSA antisera; a recently introduced monoclonal to PSA, however, was unreactive. These observations cast doubt on the specificity of PSA for prostatic epithelium, especially when polyclonal antisera are employed. Immunocytochemical reactions obtained with PSA, in the investigation of skin, lesions must be interpreted with caution and confirmed if necessary with monoclonals to PSA and with PAP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471501

Source DB:  PubMed          Journal:  Basic Appl Histochem        ISSN: 0391-7258


  9 in total

1.  A proof of principal study on the use of direct PCR of semen and spermatozoa and development of a differential isolation protocol for use in cases of alleged sexual assault.

Authors:  Shanan S Tobe; Yuvaneswari C Swaran; Lynn Dennany; Ursula Sibbing; Kristina Schulze Johann; Lindsey Welch; Marielle Vennemann
Journal:  Int J Legal Med       Date:  2016-11-10       Impact factor: 2.686

2.  Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; Edson J Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines.

Authors:  H Yu; E P Diamandis; N Zarghami; L Grass
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Detection of prostate-specific antigen immunoreactivity in breast tumors.

Authors:  E P Diamandis; H Yu; D J Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; G Bianchi; F Marcheggiani; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?

Authors:  F Mannello; G Gazzanelli
Journal:  Breast Cancer Res       Date:  2001-05-10       Impact factor: 6.466

Review 7.  Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy.

Authors:  Jeremy S Frieling; Conor C Lynch
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

8.  Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.

Authors:  R E Hall; J A Clements; S N Birrell; W D Tilley
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

9.  Expression of androgen receptor and prostate-specific antigen in male breast carcinoma.

Authors:  Noman Kidwai; Yun Gong; Xiaoping Sun; Charuhas G Deshpande; Anjana V Yeldandi; M Sambasiva Rao; Sunil Badve
Journal:  Breast Cancer Res       Date:  2003-11-07       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.